Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm.
The human immunodeficiency virus type 1 (HIV-1) Rev (regulator of virion protein expression) protein exemplifies a new type of posttranscriptional regulation. One main function of Rev is to increase the cytoplasmic expression of unspliced and incompletely spliced retroviral mRNAs from which viral structural proteins are made. In that way, Rev is essential in order to complete the retroviral life cycle. The biology of Rev in the host cell has remained elusive. In this study, a complex distribution of Rev in single cells was found. Rev was found in the cytoplasm, in a perinuclear zone, in the nucleoplasm, and in the nucleoli. In the nucleoplasm, Rev colocalized in a speckled pattern with host cell factors known to assemble on nascent transcripts. Those factors are involved in the processing of heterogeneous RNA to spliced mRNA in the nucleoplasm of all cells. The distribution of Rev was dependent only on Rev and host cell interactions, since neither the Rev target RNA nor other HIV proteins were expressed in the cells. Rev was found in the same subcellular compartments of cells treated for extended periods with cycloheximide, an inhibitor of protein synthesis. This finding implies that Rev shuttles continuously between cytoplasmic and nucleoplasmic compartments. The results suggest a potential role for Rev both in the RNA-splicing process and in the nucleocytoplasmic transport of Rev-dependent HIV mRNA.
Kalland
K H
KH
Department of Microbiology and Immunology, Gade Institute, University of Bergen, Norway.
Szilvay
A M
AM
Langhoff
E
E
Haukenes
G
G
D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000096:biosynthesis; D000918:Antibody Specificity; D001323:Autoantibodies; D001692:Biological Transport; D002451:Cell Compartmentation; D002467:Cell Nucleus / Q000737:chemistry* / Q000648:ultrastructure; D003513:Cycloheximide / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D015694:Gene Products, rev / Q000276:immunology / Q000302:isolation & purification*; D015483:HIV Antibodies / Q000096:biosynthesis; D015497:HIV-1 / Q000737:chemistry* / Q000276:immunology; D006367:HeLa Cells; D006801:Humans; D007399:Interphase / Q000502:physiology; D008969:Molecular Sequence Data; D014176:Protein Biosynthesis / Q000187:drug effects; D012326:RNA Splicing; D012342:RNA, Small Nuclear / Q000302:isolation & purification; D017411:Ribonucleoproteins, Small Nuclear / Q000302:isolation & purification; D054321:rev Gene Products, Human Immunodeficiency Virus
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D015694:Gene Products, rev; D015483:HIV Antibodies; D012342:RNA, Small Nuclear; D017411:Ribonucleoproteins, Small Nuclear; D054321:rev Gene Products, Human Immunodeficiency Virus; D003513:Cycloheximide